XML 103 R83.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share Based Compensation (Summary Of Non-Vested Share Award Activity) (Details) - $ / shares
4 Months Ended 8 Months Ended 12 Months Ended
Apr. 30, 2021
Dec. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Non Vested Share Awards, Equity Classified [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance 2,982,000,000 0 2,982,000,000    
Non-vested Granted, Shares   1,050,000,000      
Non-vested Vested, Shares (195,000,000)        
Non-vested Forfeited, Shares (295,000,000) (192,000,000)      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance 0 858,000,000 858,000,000 2,982,000,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]          
Weighted-Average Grant-Date Fair Value $ 16,400,000 $ 0 $ 16,400,000    
Non-vested Granted, Weighted-Average Grant-Date Fair Value 0 26,070,000.00   $ 3.07 $ 11.50
Non-vested Vested, Weighted-Average Grant-Date Fair Value $ 16,930,000        
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod (2,492,000,000)        
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledWeightedAverageGrantDateFairValue $ 14,250,000        
Non-vested Forfeited, Weighted-Average Grant-Date Fair Value 32,980,000 25,020,000.00      
Weighted-Average Grant-Date Fair Value $ 0 $ 26,300,000 $ 26,300,000 $ 16,400,000  
Non-Vested Share Awards, Liability Classified [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance 311,000,000 0 311,000,000    
Non-vested Granted, Shares   0      
Non-vested Vested, Shares (25,000,000)        
Non-vested Forfeited, Shares (5,000,000) 0      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance 0 0 0 311,000,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]          
Weighted-Average Grant-Date Fair Value $ 22,740,000 $ 0 $ 22,740,000    
Non-vested Granted, Weighted-Average Grant-Date Fair Value 0 0 0 $ 750,000 $ 0
Non-vested Vested, Weighted-Average Grant-Date Fair Value $ 11,350,000        
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod (281,000,000)        
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledWeightedAverageGrantDateFairValue $ 23,650,000        
Non-vested Forfeited, Weighted-Average Grant-Date Fair Value 29,180,000 0      
Weighted-Average Grant-Date Fair Value $ 0 $ 0 $ 0 $ 22,740,000  
Performance Based Awards          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance 609,000 0 609,000    
Non-vested Granted, Shares   1,312,000      
Non-vested Forfeited, Shares   (703,000)      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance 0     609,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]          
Weighted-Average Grant-Date Fair Value $ 17.53 $ 0 $ 17.53    
Non-vested Granted, Weighted-Average Grant-Date Fair Value   15.93      
Non-vested Forfeited, Weighted-Average Grant-Date Fair Value   $ 14.54      
Weighted-Average Grant-Date Fair Value $ 0     $ 17.53  
Performance Based Awards | Minimum          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]          
Non-vested Granted, Shares   0      
Performance Based Awards | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]          
Non-vested Granted, Shares   913,585      
Market-Based Objectives          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]          
Non-vested Granted, Shares   984,000      
Non-vested Forfeited, Shares   (527,000)      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]          
Non-vested Granted, Weighted-Average Grant-Date Fair Value   $ 12.09      
Non-vested Forfeited, Weighted-Average Grant-Date Fair Value   $ 11.04      
Performance-Based Objectives          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]          
Non-vested Granted, Shares   328,000      
Non-vested Forfeited, Shares   (176,000)      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]          
Non-vested Granted, Weighted-Average Grant-Date Fair Value   $ 27.44      
Non-vested Forfeited, Weighted-Average Grant-Date Fair Value   $ 25.02